ICCC Financials
Immucell Corp - Financial statements & key metrics
Stock Price
$7.54
Market Cap
$68.76M
EPS
$-0.12
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$26.49M
Gross Profit
-
Operating Income
-
Net Income
$-2.16M
EPS (Diluted)
$-0.26
Balance Sheet Highlights
Total Assets
$45.10M
Total Liabilities
$17.58M
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$357,903
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
41.4%
Operating Margin
0.1%
Net Margin
-0.0%
ROE
-0.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ICCC revenue?
ICCC's most recent quarterly revenue was $26.49M. Annual revenue can be calculated by summing the four most recent quarters.
Is ICCC profitable?
ICCC reported a loss of $2.16M in the most recent quarter. The net profit margin is -0.0%.
What is ICCC market cap?
ICCC has a market capitalization of $68.76M, making it a small-cap stock.
Does ICCC have debt?
View ICCC's balance sheet for debt information.
What is ICCC cash flow?
Cash flow data is available in the full financial statements.